The $16M USD round was led by Celesta Capital, with participation from Tenacity Ventures, Cedars Sinai; OneCell to continue transforming...
TEL AVIV, Israel, Nov. 20, 2024 /PRNewswire/ -- Converge Bio, a generative AI platform for accelerated drug discovery and development, today...
Company is evaluating IMSB301 in a Phase 1 clinical trial in healthy volunteers and plans to move rapidly into Phase...
COPENHAGEN, Denmark, Nov. 19, 2024 /PRNewswire/ -- Today marks the launch of Cmbio, a new brand that brings together Clinical Microbiomics...
NATIONAL HARBOR, Md., Nov. 19, 2024 /PRNewswire/ -- Celebrating its 14th year, Maryland-based cloud and AI consultancy Cloudforce continues to...
PALO ALTO, CA / ACCESSWIRE / November 19, 2024 / Bioz, Inc., a driving force in AI-enhanced citation tracking, is...
Phase 1 Basket Study for B Cell-mediated Autoimmune Diseases to Assess FT522 as Add-on to Standard-of-care Induction and Maintenance Regimens...
Data presented at the American Heart Association Scientific Sessions show a 67% reduction in bleeding for patients on antiplatelet therapy...
Results show the potential of a real-time, non-invasive blood test to quantify tumor drug target expression and to stratify therapeutic...
50% of patients who had baseline HBsAg levels less than 1000 IU/mL achieved functional cure in Cohort A1 of the...
Eight participants achieved HBsAg loss at any time.Two participants met criteria for functional cure. Two participants who discontinued NUC therapy...
Significantly greater mean declines in HBsAg levels (p <0.017) were seen in those receiving imdusiran, VTP-300 and low-dose nivolumab compared...
Significantly greater mean declines in HBsAg levels (p <0.017) were seen in those receiving imdusiran, VTP-300 and low-dose nivolumab compared...
The amivantamab plus lazertinib combination regimen offers potential to provide new standard of care as first-line option for adult patients...
The U.S. healthcare revenue cycle management (RCM) outsourcing market for outpatient and ancillary services is experiencing significant growth. In 2023,...
With Growing Demand in Zero Proof and Bubbly Drinks, New Dealcoholized Sparkling Brut and Sparkling Rosé Hit the Spot BOSTON,...
Ginkgo provides update on its restructuring process including an acceleration of site consolidation initiatives and continued progress on cost reductions...
SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Nuvia Dental Implant Centers, a national leader in advanced dental implant solutions,...
BOSTON, Nov. 12, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and...
Leading Company Focused on ABA Therapy for Preschool Children with Autism Expands Leadership TeamCHICAGO, Nov. 12, 2024 (GLOBE NEWSWIRE) --...